The role of subjective illness beliefs and attitude toward recovery within the relationship of insight and depressive symptoms among people with schizophrenia spectrum disorders

Journal of Clinical Psychology
Marialuisa CaveltiRoland Vauth

Abstract

Low levels of insight are a risk factor for treatment nonadherence in schizophrenia, which can contribute to poor clinical outcome. On the other hand, high levels of insight have been associated with negative outcome, such as depression, hopelessness, and lowered quality of life. The present study investigates mechanisms underlying the association of insight and depressive symptoms and protective factors as potential therapeutic targets. One hundred and forty-two outpatients with schizophrenia or schizoaffective disorder (35.2% women, mean age of 44.83 years) were studied using questionnaires and interviews to assess insight, depressive symptoms, recovery attitude, and illness appraisals with regard to course, functional impairments, and controllability. Psychotic and negative symptoms were assessed as control variables. The cross-sectional data were analyzed using structural equation models and multiple linear regression analyses with latent variables. Higher levels of insight and psychotic symptoms were associated with more depressive symptoms. The association of negative symptoms with depressive symptoms was not significant. The relationship between insight and depressive symptoms was mediated by the participants' perception...Continue Reading

References

Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Jan 1, 1995·Schizophrenia Bulletin·M J Cuesta, V Peralta
Jan 1, 1994·Acta Psychiatrica Scandinavica·M BirchwoodM Slade
Jun 1, 1993·The American Journal of Psychiatry·X F AmadorJ M Gorman
Jul 13, 1999·Community Mental Health Journal·P W CorriganI Okeke
Oct 31, 2002·The Australian and New Zealand Journal of Psychiatry·David M Clarke, David W Kissane
Mar 22, 2003·Schizophrenia Research·Alisa R MintzDavid M Romney
Feb 26, 2004·Psychological Medicine·R J DrakeS W Lewis
Jun 15, 2005·Acta Psychiatrica Scandinavica·M A CookeV Kumari
Jun 16, 2005·Schizophrenia Bulletin·Patrick W CorriganLorraine Keck
Jul 5, 2005·European Archives of Psychiatry and Clinical Neuroscience·Max BirchwoodRachel Upthegrove
Jul 12, 2005·The British Journal of Clinical Psychology·Fiona LobbanSteven Jones
Sep 2, 2006·The British Journal of Psychiatry : the Journal of Mental Science·André AlemanAnthony S David
Aug 19, 2007·Psychiatric Rehabilitation Journal·Steven J OnkenJudith A Cook
Dec 20, 2007·The Journal of Nervous and Mental Disease·Ross G WhiteCiaran Mulholland
Oct 7, 2008·Psychiatry·Charmaine C Williams
Nov 27, 2008·Psychiatric Services : a Journal of the American Psychiatric Association·Philip T YanosPaul H Lysaker
Jun 12, 2009·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Patrick W CorriganNicolas Rüsch
Feb 11, 2010·The Journal of Nervous and Mental Disease·Nicolas RüschGalen V Bodenhausen
Aug 6, 2010·Schizophrenia Research·Elizabeth A BarrettIngrid Melle
Aug 31, 2010·American Journal of Psychiatric Rehabilitation·Philip T YanosPaul H Lysaker

❮ Previous
Next ❯

Citations

Apr 6, 2013·Perspectives in Psychiatric Care·Soon Ah Park, Kyung Mi Sung
Feb 24, 2016·International Journal of Psychiatry in Clinical Practice·Dario CannavòEugenio Aguglia
Apr 1, 2015·Schizophrenia Research·Carmen ValienteFranziska Everts
Oct 10, 2012·Schizophrenia Research·Nyaz DidehbaniDaniel C Krawczyk
Feb 6, 2014·Psychiatry Research·Kristin KlapheckThomas Bock
Jul 30, 2014·Community Mental Health Journal·Laura GiustiRita Roncone
Dec 20, 2017·Journal of Mental Health·Josephine S LarkingsBrett Scholz
Jun 17, 2014·The Journal of Nervous and Mental Disease·Marialuisa CaveltiRoland Vauth
Aug 1, 2013·Expert Review of Neurotherapeutics·Paul H LysakerGiancarlo Dimaggio
Sep 9, 2017·Expert Review of Neurotherapeutics·Bethany L LeonhardtPaul H Lysaker
Aug 2, 2017·European Archives of Psychiatry and Clinical Neuroscience·Yin-Ju LienChing-Hui Loh
Jan 25, 2021·Journal of Psychiatric Research·Sjors M M LangeUNKNOWN GROUP investigators
Jul 27, 2021·Early Intervention in Psychiatry·Tze Kwan KamWing Chung Chang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.